The longer you had Facebook from 2007 through 2022, the bigger your share of the settlement will be. But you had to file a ...

Shakuniya Solutions, an Indian software developer and IT consultant, has developed a comprehensive digital ecosystem that ...

Discover how to optimize LC×LC orthogonality for organic micropollutants analysis, enhancing method development with a new ...

Nvidia, the world's leading manufacturer of AI chips, and the most valuable company in the world with a $4.2 trillion market ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studiesIcotrokinra also showed ...

The Massachusetts bank is being accused of aiding and abetting the operation of a Ponzi scheme centered in Hamilton, New York ...

Short Duration High Yield Municipal Fund A Shares (without sales charge) posted a return of -0.17% in second quarter of 2025.

C,” reads my phone’s weather app, as a violent wind howls across the field at Loughborough University. The trees on campus ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

After a gap of two decades, the UK Royal Navy (RN) is reintroducing an influence minesweeping capability as part of the ...

After a torrid year on and outside markets, Cbus is looking for returns from the sort of stuff you can stub your toe on.

Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and ...